<?xml version="1.0" encoding="UTF-8"?>
<p>In 2001, an outbreak of encephalitis occurred in Taiwan, China. One thousand one hundred thirty cases of enterovirus infection were reported, and the detection rate of E-30 was 16.6% (
 <xref rid="B49" ref-type="bibr">Wang et al., 2002</xref>). In Jiangsu Province of China in 2003, 1,681 patients with encephalitis were reported, and E-30 was confirmed as the etiologic agent of this outbreak (
 <xref rid="B63" ref-type="bibr">Zhao et al., 2005</xref>). Similar incidences of E-30 outbreaks were reported in Shandong Province of China, showing that E-30 was a major pathogen in encephalitis patients (
 <xref rid="B45" ref-type="bibr">Tao et al., 2014</xref>). The outbreaks of E-30, which were closely associated with encephalitis, were also frequently reported in other parts of the world, including Italy, Bulgaria, France, United Kingdom, Spain, Brazil, and Korea (
 <xref rid="B7" ref-type="bibr">Cabrerizo et al., 2008</xref>; 
 <xref rid="B54" ref-type="bibr">Yang et al., 2013</xref>; 
 <xref rid="B31" ref-type="bibr">Mladenova et al., 2014</xref>; 
 <xref rid="B19" ref-type="bibr">Holmes et al., 2016</xref>). Surprisingly, a recent report showed that E-30 was detected in an outbreak of acute myalgia and rhabdomyolysis, indicating that E-30 possibly caused severe non-neuropathic diseases and that E-30 could cause a variety of clinical symptoms (
 <xref rid="B42" ref-type="bibr">Sousa et al., 2019</xref>).
</p>
